SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rossari Biotech - Quaterly Results

29 Apr 2023 Evaluate
The quarter ended March 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 2636.42 millions.Good  Net Profit growth of 37.13% reported above the corresponding previous quarter figure of Rs. 168.74 millions to Rs. 231.39 millioins.OP of the company witnessed a marginal growth to 381.08 millions from 294.01 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 2636.42 2616.41 0.76 9751.72 10728.44 -9.10 9751.72 10728.44 -9.10
Other Income 23.19 19.35 19.84 35.98 127.00 -71.67 35.98 127.00 -71.67
PBIDT 381.08 294.01 29.61 1262.46 1354.93 -6.82 1262.46 1354.93 -6.82
Interest 11.63 6.05 92.23 46.18 25.45 81.45 46.18 25.45 81.45
PBDT 369.45 287.96 28.30 1216.28 1329.48 -8.51 1216.28 1329.48 -8.51
Depreciation 67.16 70.80 -5.14 259.83 262.68 -1.08 259.83 262.68 -1.08
PBT 302.29 217.16 39.20 956.45 1066.80 -10.34 956.45 1066.80 -10.34
TAX 70.90 48.42 46.43 242.55 272.06 -10.85 242.55 272.06 -10.85
Deferred Tax -9.27 -11.06 -16.18 -17.11 -15.09 13.39 -17.11 -15.09 13.39
PAT 231.39 168.74 37.13 713.90 794.74 -10.17 713.90 794.74 -10.17
Equity 110.31 110.11 0.18 110.31 110.11 0.18 110.31 110.11 0.18
PBIDTM(%) 14.45 11.24 28.63 12.95 12.63 2.51 12.95 12.63 2.51

Rossari Biotech Share Price

480.15 1.40 (0.29%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×